Price$0.60-0.04 (-5.76%)
02:00 PM07:45 PM
News · 26 weeks14+100%
2025-10-262026-04-19
Mix1190d
- SEC Filings5(45%)
- Offering3(27%)
- Other3(27%)
Latest news
25 items- SECSEC Form S-1 filed by DSS Inc.S-1 - DSS, INC. (0000771999) (Filer)
- PRDSS, Inc. Letter to ShareholdersROCHESTER, N.Y., April 15, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) today issued the following letter to shareholders from the Interim CEO, Jason Grady, highlighting the Company's operational progress, financial improvements, and strategic initiatives. Dear Fellow Shareholders, Over the past six months, our stock performance has not fully reflected the progress we have made inside DSS. While we recognize the importance of market perception, it is equally important to separate short-term trading dynamics from the underlying trajectory of the business. Today, our valuation continues to be influenced by legacy financial results, balance sheet considerations, and the complexity of hist
- SECDSS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - DSS, INC. (0000771999) (Filer)
- SECSEC Form 10-K filed by DSS Inc.10-K - DSS, INC. (0000771999) (Filer)
- SECSEC Form DEF 14C filed by DSS Inc.DEF 14C - DSS, INC. (0000771999) (Filer)
- SECSEC Form PRER14C filed by DSS Inc.PRER14C - DSS, INC. (0000771999) (Filer)
- SECDSS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits8-K - DSS, INC. (0000771999) (Filer)
- PRDSS, Inc. Announces Closing of $1.0 Million Underwritten Public OfferingNEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the closing of its previously announced firm commitment underwritten public offering. Gross proceeds to the Company were approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering consisted of 900,000 shares of common stock. The public offering price per share of common stock was $1.00. In addition, the Company granted Aegis Capital Corp., the underwriter, an ov
- SECSEC Form 424B5 filed by DSS Inc.424B5 - DSS, INC. (0000771999) (Filer)
- PRDSS, Inc. Announces Pricing of $1.0 Million Underwritten Public OfferingNEW YORK, Feb. 04, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including product packaging, biotechnology, commercial lending, and securities and investment management, today announced the pricing of a firm commitment underwritten public offering with gross proceeds to the Company expected to be approximately $1.0 million, before deducting underwriting fees and other offering expenses payable by the Company. The offering consists of 900,000 shares of common stock. The public offering price per share of common stock is $1.00. In addition, the Company has granted the underwriter an overallotment option to purchas
- PRDSS, Inc. Announces Launch of Proposed Public OfferingNEW YORK, Feb. 03, 2026 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) (the "Company"), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that it has commenced a public offering to offer and sell shares of its Common Stock. All of the shares of Common Stock are being offered by the Company (the "Offering"). The Company intends to use the net proceeds from the Offering for general corporate and working capital needs. The Company's Common Stock is trading on the NYSE American LLC under the symbol "DSS". The Offering is subject to market conditions, and there can be no assurance as to whether or when the O
- SECSEC Form PRE 14C filed by DSS Inc.PRE 14C - DSS, INC. (0000771999) (Filer)
- SECDSS Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - DSS, INC. (0000771999) (Filer)
- SECSEC Form 10-Q filed by DSS Inc.10-Q - DSS, INC. (0000771999) (Filer)
- SECSEC Form DEFR14A filed by DSS Inc.DEFR14A - DSS, INC. (0000771999) (Filer)
- SECSEC Form DEF 14A filed by DSS Inc.DEF 14A - DSS, INC. (0000771999) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by DSS Inc.SCHEDULE 13D/A - DSS, INC. (0000771999) (Subject)
- INSIDERDirector Chan Heng Fai Ambrose increased direct ownership by 14% to 1,053,796 units (SEC Form 4)4 - DSS, INC. (0000771999) (Issuer)
- NEWSI-ON Digital Strengthens Leadership With Key Board Appointments of Patrick White and John JubileeIndustry Veterans Bring Expertise in Security Technology, Capital Markets, Health & Wellness, and Strategic Leadership to Support Growth in Real-World Asset Digitization CHICAGO, IL / ACCESS Newswire / September 2, 2025 / I-ON Digital Corp. (OTCQB:IONI), a leader in real-world asset (RWA) digitization through blockchain-secured technologies, today announced the appointment of Patrick White and John Jubilee to its Board of Directors. These entrepreneurial additions bring extensive and unique expertise in security technology, capital markets, decentralized SaaS platforms, and transformational leadership, strengthening I-ON's governance as it drives next-generation Web3 financial technology and
- SECAmendment: SEC Form SCHEDULE 13D/A filed by DSS Inc.SCHEDULE 13D/A - DSS, INC. (0000771999) (Subject)
- SECSEC Form 10-Q filed by DSS Inc.10-Q - DSS, INC. (0000771999) (Filer)
- SECDSS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits8-K - DSS, INC. (0000771999) (Filer)
- SECDSS Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant8-K - DSS, INC. (0000771999) (Filer)
- PRDSS, Inc.'s Subsidiary, Impact BioMedical Inc., Announces Strategic MergerNEW YORK, June 24, 2025 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE:DSS) ("DSS" or the "Company"), a multinational company operating across diverse industries including packaging, wealth management, and biohealth innovation, today announced that its subsidiary, Impact BioMedical Inc. ("Impact"), has entered into a definitive merger agreement (the "Merger Agreement") with Dr. Ashleys Limited ("Dr. Ashleys"), a global pharmaceutical company. Under the terms of the agreement, Dr. Ashleys will acquire Impact through a reverse merger that will result in a newly formed combined entity (the "PubCo") traded on the NYSE American under the name "Dr Ashleys Limited." This strategic transaction marks an imp
- INSIDERLarge owner Dss, Inc. sold $88,006 worth of shares (161,000 units at $0.55), closing all direct ownership in the company (SEC Form 4)4 - DSS, INC. (0000771999) (Reporting)